Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Leuk Res. 2015 Mar 28;39(6):586–591. doi: 10.1016/j.leukres.2015.03.013

Table I.

Patient Characteristics (N=610)

Characteristics N %
Age (years)
 <65 16 2.6
 65 – 74 160 26.2
 75 – 84 318 52.1
 85+ 116 19.0
Sex
 Male 347 56.9
 Female 263 43.1
Race
 White 557 91.3
 Black 17 2.8
 Other 36 5.9
MDS risk category
 Low-risk 170 27.9
 High-risk 153 25.1
 Risk not specified 287 47.1
Comorbidities
 Congestive heart failure 87 14.3
 Ischemic heart disease 218 35.7
 Peripheral vascular disease 39 6.4
 Cerebrovascular disease 30 4.9
 Myocardial infarction 32 5.3
 Diabetes or diabetes with complications 107 17.5
 Chronic obstructive pulmonary disease 121 19.8
 Rheumatologic disease 20 3.3
 Depression or schizophrenia 38 6.2
 Alzheimer’s disease 30 4.9
 Ulcer 15 2.5

Low-risk (RA, RARS, RCMD, 5q del); High-risk (RAEB); Risk not specified (Therapy-related MDS and MDS, NOS)